Iovance Stock Been Hammered: A Buying Opportunity or Lure for Risky Bets
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Compare capital gains tax exposure between ETFs and index funds in retirement, and choose the option with better tax efficiency.
28,430 articlesIovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
May's initial jobless claims rose to a four-month high, but the spike is tied to Memorial Day timing rather than a br...
Investors are watching the Fed closely as warnings mount. This guide explains why the federal reserve raising flags m...
As year-to-date markets swing, Disney and PayPal stand out as potential rebound plays. This article weighs dividends,...
Investors rotated into AI infrastructure plays this week, lifting Argan and similar names. This piece breaks down the...
A fresh look at HAIN's Q3 2026 earnings and what it means for investors. Learn the metrics that matter, how to read t...
SkyX’s Q1 2026 results hint at a company in transition: solid top-line momentum paired with ongoing investments. This...
If you’re worried about stock market volatility, defensive dividend stocks can help. This guide covers smart picks, s...
A veteran strategist warns that the odds stock market meltdown could jump to 35% this year as oil shocks and sluggish...
A sudden antivirus alert can look legitimate—until you realize it's a scam. This article breaks down how these tricks...
A real-world tech-support scam drained a couple’s life savings before authorities stopped the final transfer. This in...
The U.S. signals broader military targets in Iran as tensions flare, sending oil higher and putting pressure on house...